Sign In
Buy ZYME
$24.35
+0.240 (+1.00%)
At Close: Jun 03, 2026
Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
06:15pm, Monday, 18'th Dec 2023
We've all had the experience of emptying our pockets at day's end to find a collection of coins. Sure, you could cash them in at a Coinstar machine for some bills.
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
12:04pm, Wednesday, 13'th Dec 2023
The pandemic pushed major biotech stocks into the spotlight as vaccine demands rose to unprecedented highs. Investors flocked to the industry in the next few years after the COVID-19 breakout.
The 7 Best Bargain Growth Stocks to Buy Before 2024
04:17pm, Monday, 11'th Dec 2023
When you hear the term “growth stocks,” you probably think of high-growth yet unprofitable companies diluting shareholders through secondary offerings just to fund more losses. But that doesn't al
Does Zymeworks Inc. (ZYME) Have the Potential to Rally 42.84% as Wall Street Analysts Expect?
11:18am, Friday, 01'st Dec 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in Zymeworks Inc. (ZYME). While the effectiveness of this highly sought-after metric is questionable, the
Zymeworks Announces Participation in Upcoming Investor Conference
08:30am, Thursday, 30'th Nov 2023
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced
3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years
07:00am, Thursday, 30'th Nov 2023
After over a decade of smooth sailing, stocks have been exceptionally turbulent for the past three years. Rising rates, high inflation, recession fears – you name it, and the bears have used it to m
Zymeworks Inc. (ZYME) Q3 2023 Earnings Call Transcript
10:07pm, Tuesday, 07'th Nov 2023
Zymeworks Inc. (NASDAQ:ZYME ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Shrinal Inamdar – Director-Investor Relations Chris Astle – Senior Vice President an
Zymeworks Announces Participation in Upcoming Investor Conferences
08:30am, Wednesday, 01'st Nov 2023
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced
Zymeworks To Host Third Quarter 2023 Results Conference Call
08:30am, Tuesday, 17'th Oct 2023
VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced
Adding Zymeworks To My Value Watchlist (Initial Buy Rating)
03:06am, Monday, 11'th Sep 2023
Zymeworks is a biotech company focused on developing therapies for hard-to-treat cancers. Its lead product, zanidatamab, has shown promising results in clinical trials and has been partnered with larg
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
07:07pm, Wednesday, 16'th Aug 2023
Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.
Zymeworks Inc. (ZYME) Q2 2023 Earnings Call Transcript
10:19pm, Thursday, 10'th Aug 2023
Zymeworks Inc. (NASDAQ:ZYME ) Q2 2023 Earnings Call August 10, 2023 4:30 PM ET Company Participants Diana Papove - Director of Corporate Communications Chris Astle - Senior Vice President and Chief Fi
Zymeworks Inc. (ZYME) Reports Q2 Loss, Lags Revenue Estimates
07:01pm, Thursday, 10'th Aug 2023
Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.97 per share a year ago.
Zymeworks Announces Participation in Upcoming Investor Conferences
08:30am, Tuesday, 01'st Aug 2023
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced
7 Small-Cap Stocks to Buy Before the Breakout
06:00am, Thursday, 27'th Jul 2023
When dealing with the best small-cap stocks to buy, investors effectively absorb higher risk for the possibility of substantive rewards. Even better, these rewards can come in quickly, enabling those
